Clinical trial / 2023
Ginkgo biloba combined with antioxidants significantly improved tinnitus handicap, visual analogue, and quality-of-life scores compared to placebo or Ginkgo alone.
Sixty-nine tinnitus patients aged 40-70 were randomized to receive placebo (n=22), Ginkgo biloba (60 mg twice daily) alone (n=24), or Ginkgo biloba combined with antioxidants (n=23) across 14 weeks. Supplementation with Ginkgo biloba plus antioxidants produced marked improvement (p<0.05) in post-treatment THI and VAS scores compared to Ginkgo alone and placebo. The greatest percent differences pre- and post-treatment in the combination group were -36% for THI and -22.6% for VAS (p<0.05), alongside significant improvements in various SF-36 quality-of-life parameters.
- Study type
- Randomized controlled trial
- Who was studied
- 69 patients aged 40-70 years (41 men, 28 women) with tinnitus
- What was measured
- Tinnitus Handicap Index (THI), Visual Analogue Score (VAS), and SF-36 Health Scores
THE PAPER
Ginkgo biloba Administered Singly and Combined With Antioxidants in Tinnitus Patients.
Chauhan B, Arya S, Chauhan K. J Audiol Otol, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.